Kefeng Zeng1, Hong-Qi Zhang2, Yong Chen1, Qile Gao1. 1. Department of Spine Surgery, Xiangya Hospital of Central South University, Xiangya Road 87, Changsha, 410008, China. 2. Department of Spine Surgery, Xiangya Hospital of Central South University, Xiangya Road 87, Changsha, 410008, China. zhq9996@163.com.
Abstract
PURPOSE: Abnormal growth of vertebral growth plate (VGP) was considered as one of the etiologic factors in adolescent idiopathic scoliosis (AIS). Previous studies described that estrogen played an important role in the pathogenesis of AIS. The present study was aimed to investigate the effect of estrogen/estrogen receptor axis on mouse VGP chondrocytes in vitro. METHODS: Chondrocytes were isolated from mouse VGP and treated with or without 17β-estradiol (E2). Cell proliferation was measured by the cell growth rate assay. Gene expression of collagen type II and aggrecan were evaluated by real-time PCR. Expression of the proliferating cell nuclear antigen (PCNA), Sox9, and Smad4 were detected by Western blotting. RESULTS: Estradiol inhibited the proliferation of VGP chondrocytes and the gene expression of collagen type II and aggrecan and downregulated the protein expression of PCNA, Sox9, and Smad4. In addition, the inhibitory effect of estradiol was reversed by ERβ small interfering RNA (siRNA) or PHTPP, an ERβ antagonist. CONCLUSIONS: Estradiol via estrogen/estrogen receptor β axis inhibits the proliferation and differentiation of VGP chondrocytes, which might give some new insight into the regulatory mechanism of bone development.
PURPOSE:Abnormal growth of vertebral growth plate (VGP) was considered as one of the etiologic factors in adolescent idiopathic scoliosis (AIS). Previous studies described that estrogen played an important role in the pathogenesis of AIS. The present study was aimed to investigate the effect of estrogen/estrogen receptor axis on mouse VGP chondrocytes in vitro. METHODS: Chondrocytes were isolated from mouse VGP and treated with or without 17β-estradiol (E2). Cell proliferation was measured by the cell growth rate assay. Gene expression of collagen type II and aggrecan were evaluated by real-time PCR. Expression of the proliferating cell nuclear antigen (PCNA), Sox9, and Smad4 were detected by Western blotting. RESULTS:Estradiol inhibited the proliferation of VGP chondrocytes and the gene expression of collagen type II and aggrecan and downregulated the protein expression of PCNA, Sox9, and Smad4. In addition, the inhibitory effect of estradiol was reversed by ERβ small interfering RNA (siRNA) or PHTPP, an ERβ antagonist. CONCLUSIONS:Estradiol via estrogen/estrogen receptor β axis inhibits the proliferation and differentiation of VGP chondrocytes, which might give some new insight into the regulatory mechanism of bone development.
Authors: J Chen; Y Kamiya; I Polur; M Xu; T Choi; Z Kalajzic; H Drissi; S Wadhwa Journal: Osteoarthritis Cartilage Date: 2014-07-18 Impact factor: 6.576
Authors: Anna E Börjesson; Marie K Lagerquist; Chen Liu; Ruijin Shao; Sara H Windahl; Camilla Karlsson; Klara Sjögren; Sofia Movérare-Skrtic; Maria Christina Antal; Andrée Krust; Subburaman Mohan; Pierre Chambon; Lars Sävendahl; Claes Ohlsson Journal: J Bone Miner Res Date: 2010-06-18 Impact factor: 6.741
Authors: Abdul Haseeb; Ranjan Kc; Marco Angelozzi; Charles de Charleroy; Danielle Rux; Robert J Tower; Lutian Yao; Renata Pellegrino da Silva; Maurizio Pacifici; Ling Qin; Véronique Lefebvre Journal: Proc Natl Acad Sci U S A Date: 2021-02-23 Impact factor: 11.205
Authors: Oliver R Oakley; Kee Jun Kim; Po-Ching Lin; Radwa Barakat; Joseph A Cacioppo; Zhong Li; Alexandra Whitaker; Kwang Chul Chung; Wenyan Mei; CheMyong Ko Journal: Endocrinology Date: 2016-10-25 Impact factor: 4.736